Company Filing History:
3 out of 46 
2 out of 68 
Years Active: 2013-2025
Title: Innovations by Joel Lechner
Introduction
Joel Lechner is an accomplished inventor based in Omaha, Nebraska. He has made significant contributions to the field of microbial resistance through his innovative patents. With a total of three patents to his name, Lechner's work focuses on the detection and determination of microbial resistance to beta-lactam antibiotics.
Latest Patents
Lechner's latest patents include assays and methods for determining microbial resistance. These patents detail methods for detecting resistance to beta-lactam antibiotics, including the detection of multiple β-lactamase family specific gene targets by polymerase chain reaction or microarray. His inventions also encompass kits that include primers and/or probes for the identification of β-lactamase genes. These genes are selected from a comprehensive group, including MOX-like, FOX-like, ACC-like, ACT/MIR-like, CMY-2-like, DHA-like, CTX-M-14-like, CTX-M-15-like, VIM-like, NDM-like, IMP-like, KPC-like, and OXA-48-like, among others. Additionally, his kits may include primers and/or probes for identifying non-beta lactamase gene families that confer antibiotic resistance, such as the MCR-1 gene.
Career Highlights
Throughout his career, Joel Lechner has worked with notable organizations, including Streck, Inc. and Creighton University. His experience in these institutions has allowed him to develop and refine his innovative approaches to microbial resistance.
Collaborations
Lechner has collaborated with several professionals in his field, including Maria Torres-Gonzalez and Nancy D. Hanson. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Joel Lechner's contributions to the field of microbial resistance through his innovative patents highlight his expertise and dedication. His work continues to impact the medical community and advance the understanding of antibiotic resistance.